Company profile
Evestia Clinical
Evestia Clinical is a leading global specialist CRO, offering a full suite of customized clinical development services.
- Industry
- Biotechnology Research
- Employees
- 127
- Headquarters
- Hertfordshire
- Founded
- 1996
- Office locations
- 6
Evestia Clinical company summary
Evestia Clinical is a company in the Biotechnology Research industry, headquartered in Hertfordshire, founded in 1996. On LinkedIn the company has around 127 employees. The company lists 6 office locations. Its listed specialties include Oncology, Neurology, Medical Research, Rare Diseases, Clinical Development.
What technology does Evestia Clinical use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Evestia Clinical
Evestia Clinical is a global specialist Contract Research Organization (CRO) dedicated to accelerating the development of life-changing therapies for biotech innovators. Formerly known as EMAS Pharma and acquired by Kester Capital in December 2024, we entered a new chapter in 2025 through our strategic merger with Atlantic Research Group (ARG). Together, we have united two highly complementary organizations to create a leading mid-tier CRO with expanded global reach, enhanced therapeutic expertise, and a full-service clinical trial offering. With headquarters in Letchworth, UK, and Charlottesville, Virginia, USA, our combined team of over 150 professionals delivers tailored solutions across the full drug development lifecycle—from Phase 1 through Phase 3 and beyond. This merger strengthens our capabilities in oncology, rare diseases, immunology, and inflammation, while adding deep expertise in neurology and late-stage clinical trial services. Our clients benefit from: • Global Infrastructure: Seamless access to international trial networks and regulatory expertise. • Expanded Therapeutic Reach: Specialized services in high-research areas including ALS/MND, oncology, and neurology. • Integrated Technology Platforms: Enhanced data management, biostatistics, and trial oversight tools. • Experienced Leadership: A proven executive team with a track record of building market-leading CROs, now joined by ARG’s senior leadership. At Evestia Clinical, we empower biotech innovators by providing expert-driven, agile, and personalized clinical research solutions—accelerating the development of life-changing therapies with confidence and care.
Specialties
Where is Evestia Clinical located?
Evestia Clinical lists 6 office locations.
Compare companies similar to Evestia Clinical
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Evestia Clinical evestiaclinical.com | Biotechnology Research | 127 | 1996 | Hertfordshire |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Evestia Clinical
What does Evestia Clinical do?
Evestia Clinical is a global specialist Contract Research Organization (CRO) dedicated to accelerating the development of life-changing therapies for biotech innovators. Formerly known as EMAS Pharma and acquired by Kester Capital in December 2024, we entered a new chapter in 2025 through our strategic merger with Atlantic Research Group (ARG). Together, we have united two highly complementary organizations to create a leading mid-tier CRO with expanded global reach, enhanced therapeutic expertise, and a full-service clinical trial offering. With headquarters in Letchworth, UK, and Charlottesville, Virginia, USA, our combined team of over 150 professionals delivers tailored solutions across the full drug development lifecycle—from Phase 1 through Phase 3 and beyond. This merger strengthens our capabilities in oncology, rare diseases, immunology, and inflammation, while adding deep expertise in neurology and late-stage clinical trial services. Our clients benefit from: • Global Infrastructure: Seamless access to international trial networks and regulatory expertise. • Expanded Therapeutic Reach: Specialized services in high-research areas including ALS/MND, oncology, and neurology. • Integrated Technology Platforms: Enhanced data management, biostatistics, and trial oversight tools. • Experienced Leadership: A proven executive team with a track record of building market-leading CROs, now joined by ARG’s senior leadership. At Evestia Clinical, we empower biotech innovators by providing expert-driven, agile, and personalized clinical research solutions—accelerating the development of life-changing therapies with confidence and care.
How many employees does Evestia Clinical have?
Evestia Clinical has around 127 employees on LinkedIn.
Where is Evestia Clinical headquartered?
Evestia Clinical is headquartered in Hertfordshire.
Where does Evestia Clinical have offices?
Evestia Clinical lists 6 office locations, including Hertfordshire, GB, GB; Charlottesville, VA, US; Iluka, Western Australia, AU; Munich, Bavaria, DE; Steinhausen, 96312, CH.
When was Evestia Clinical founded?
Evestia Clinical was founded in 1996.
Build a lead list from companies like Evestia Clinical
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.